Bridgepoint, a publicly owned company headquartered in the UK, was founded in 1999 and employs approximately 510 individuals. The firm functions as a London-headquartered private investment firm, specializing in investment management with a strong presence across Europe, China, and the US.
On June 25, 2026, Bridgepoint issued its second euro Collateralized Loan Obligation (CLO) of the year, with the Triple-A notes pricing 4 basis points wider than those in its previous deal. Previously, on June 14, Bridgepoint weighed a potential $1 billion sale of MyDefence, a Danish counter-drone company providing airspace security for the 2026 FIFA World Cup. This followed the UK investment firm's agreement on June 10 to acquire skincare company Obagi Medical from Waldencast. Bridgepoint aims to expand its clinical skincare presence with the acquisition, while Waldencast cited balance sheet constraints for the divestment. Earlier in the month, on June 8, Bridgepoint's Bridgepoint Growth small-cap fund acquired a majority stake in Stockfiller AB, a company leveraging digital technologies for growth.
Similar Companies
Subscribe for full access to Bridgepoint's profile
Subscribe for full access to Bridgepoint's products in full detail
Subscribe for full access to Bridgepoint's revenue in full detail
Subscribe for full access to Bridgepoint's products in full detail 
